阻塞性睡眠呼吸暂停与2型糖尿病患者视网膜病变的纵向研究
本研究在2型糖尿病患者中评估阻塞性睡眠呼吸暂停(OSA)与糖尿病视网膜病变(DR)的关系及进展。共纳入230例患者,OSA患病率63.9%,威胁视力DR(STDR)患病率36.1%。OSA与STDR独立相关(OR 2.3),且OSA是DR进展的独立预测因子(OR 5.2),持续气道正压治疗与进展风险降低相关。
要点
- OSA与2型糖尿病患者STDR患病率升高独立相关(OR 2.3)。
- OSA是DR进展至增殖前/增殖期的独立预测因子(OR 5.2)。
- 持续气道正压治疗与增殖前/增殖期DR风险降低相关。
核心结论
- OSA与2型糖尿病患者的STDR相关,且是DR进展的独立预测因子。
- 持续气道正压治疗与增殖前/增殖期DR风险降低相关。
研究设计与样本
- 纵向研究,在英国两家医院糖尿病门诊进行,排除已知呼吸系统疾病(包括OSA)患者。
- 共纳入230例2型糖尿病患者,DR通过双眼45度两视野视网膜图像评估,OSA通过家庭多通道心肺设备评估。
主要发现
- STDR患病率36.1%,OSA患病率63.9%。
- OSA患者STDR患病率高于无OSA患者(42.9% vs. 24.1%;P=0.004)。
- 校正混杂因素后,OSA仍与STDR独立相关(OR 2.3;95%CI 1.1-4.9;P=0.04)。
- 中位随访43.0(IQR 37.0-51.0)个月,OSA患者更易发生增殖前/增殖期DR(18.4% vs. 6.1%;P=0.02)。
- 校正混杂因素后,OSA是进展至增殖前/增殖期DR的独立预测因子(OR 5.2;95%CI 1.2-23.0;P=0.03)。
关键数值与推荐
- STDR患病率36.1%,OSA患病率63.9%。
- OSA与STDR独立相关(OR 2.3;95%CI 1.1-4.9;P=0.04)。
- OSA预测DR进展(OR 5.2;95%CI 1.2-23.0;P=0.03)。
- OSA患者增殖前/增殖期DR发生率18.4% vs. 无OSA患者6.1%(P=0.02)。
临床怎么用
- 对2型糖尿病合并OSA的患者应关注DR筛查与随访。
- 持续气道正压治疗可能降低DR进展风险,但需干预性研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Obstructive sleep apnea (OSA) is associated with several pathophysiological deficits found in diabetic retinopathy (DR). Hence, it's plausible that OSA could play a role in the pathogenesis of sight-threatening DR (STDR). OBJECTIVES: To assess the relationship between OSA and DR in patients with type 2 diabetes and to assess whether OSA is associated with its progression. METHODS: A longitudinal study was conducted in diabetes clinics within two U.K. hospitals. Patients known to have any respiratory disorder (including OSA) were excluded. DR was assessed using two-field 45-degree retinal images for each eye. OSA was assessed using a home-based multichannel cardiorespiratory device. MEASUREMENTS AND MAIN RESULTS: A total of 230 patients were included. STDR and OSA prevalence rates were 36.1% and 63.9%, respectively. STDR prevalence was higher in patients with OSA than in those without OSA (42.9% vs. 24.1%; P = 0.004). After adjustment for confounders, OSA remained independently associated with STDR (odds ratio, 2.3; 95% confidence interval, 1.1-4.9; P = 0.04). After a median (interquartile range) follow-up of 43.0 (37.0-51.0) months, patients with OSA were more likely than patients without OSA to develop preproliferative/proliferative DR (18.4% vs. 6.1%; P = 0.02). After adjustment for confounders, OSA remained an independent predictor of progression to preproliferative/proliferative DR (odds ratio, 5.2; 95% CI confidence interval, 1.2-23.0; P = 0.03). Patients who received continuous positive airway pressure treatment were significantly less likely to develop preproliferative/proliferative DR. CONCLUSIONS: OSA is associated with STDR in patients with type 2 diabetes. OSA is an independent predictor for the progression to preproliferative/proliferative DR. Continuous positive airway pressure treatment was associated with reduction in preproliferative/proliferative DR. Interventional studies are needed to assess the impact of OSA treatment on STDR.
引用
- Altaf QA, Dodson P, Ali A, et al. Obstructive Sleep Apnea and Retinopathy in Patients with Type 2 Diabetes. A Longitudinal Study. Am J Respir Crit Care Med. 2017. PMID: 28594570. doi:10.1164/rccm.201701-0175OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。